KR840006014A - 간염 b비루스 백신의 제조방법 - Google Patents

간염 b비루스 백신의 제조방법 Download PDF

Info

Publication number
KR840006014A
KR840006014A KR1019830004194A KR830004194A KR840006014A KR 840006014 A KR840006014 A KR 840006014A KR 1019830004194 A KR1019830004194 A KR 1019830004194A KR 830004194 A KR830004194 A KR 830004194A KR 840006014 A KR840006014 A KR 840006014A
Authority
KR
South Korea
Prior art keywords
fragment
hbsag
yeast
regulatory
hindiii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019830004194A
Other languages
English (en)
Korean (ko)
Inventor
테레사 카베존 (외3)
Original Assignee
원본미기재
스미스 클라인-알아이티
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 원본미기재, 스미스 클라인-알아이티 filed Critical 원본미기재
Publication of KR840006014A publication Critical patent/KR840006014A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019830004194A 1982-09-08 1983-09-06 간염 b비루스 백신의 제조방법 Ceased KR840006014A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41578982A 1982-09-08 1982-09-08
US06/415789? 1982-09-08

Publications (1)

Publication Number Publication Date
KR840006014A true KR840006014A (ko) 1984-11-21

Family

ID=23647197

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830004194A Ceased KR840006014A (ko) 1982-09-08 1983-09-06 간염 b비루스 백신의 제조방법

Country Status (22)

Country Link
EP (1) EP0106828B1 (cg-RX-API-DMAC7.html)
JP (5) JPS5971694A (cg-RX-API-DMAC7.html)
KR (1) KR840006014A (cg-RX-API-DMAC7.html)
AT (1) ATE91718T1 (cg-RX-API-DMAC7.html)
AU (4) AU584580B2 (cg-RX-API-DMAC7.html)
CA (1) CA1222707A (cg-RX-API-DMAC7.html)
CY (1) CY1932A (cg-RX-API-DMAC7.html)
DE (1) DE3382704T2 (cg-RX-API-DMAC7.html)
DK (1) DK406483A (cg-RX-API-DMAC7.html)
ES (4) ES8506350A1 (cg-RX-API-DMAC7.html)
FI (1) FI833205A7 (cg-RX-API-DMAC7.html)
GR (1) GR78982B (cg-RX-API-DMAC7.html)
HK (1) HK1004570A1 (cg-RX-API-DMAC7.html)
HU (1) HU196625B (cg-RX-API-DMAC7.html)
IE (1) IE60387B1 (cg-RX-API-DMAC7.html)
IL (1) IL69202A (cg-RX-API-DMAC7.html)
MA (1) MA19895A1 (cg-RX-API-DMAC7.html)
MY (1) MY102920A (cg-RX-API-DMAC7.html)
NO (1) NO833198L (cg-RX-API-DMAC7.html)
NZ (1) NZ204952A (cg-RX-API-DMAC7.html)
PT (1) PT77265B (cg-RX-API-DMAC7.html)
ZA (1) ZA836658B (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5936699A (ja) * 1982-08-20 1984-02-28 Chemo Sero Therapeut Res Inst シヤトルベクタ−
JPS5931799A (ja) * 1982-08-16 1984-02-20 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えプラスミド
WO1986007384A1 (fr) * 1985-06-03 1986-12-18 Takeda Chemical Industries, Ltd. Procede de preparation de l'antigene p31 de surface du virus de l'hepatite b
WO1986003411A1 (fr) * 1984-12-12 1986-06-19 Takeda Chemical Industries, Ltd. Procede de preparation d'une nouvelle proteine
WO1986001534A1 (fr) * 1984-09-04 1986-03-13 Takeda Chemical Industries, Ltd. Adn recombinant et son utilisation
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
DE3677851D1 (de) * 1985-08-05 1991-04-11 Merck & Co Inc Verfahren zur steigerung der produktion von rekombinantem protein in hefearten der gattung saccharomyces.
US4895800A (en) * 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
ZA88488B (en) * 1987-01-30 1988-10-26 Smith Kline Rit Hepatitis b virus surface antigens and hybrid antigens containing them
ATE93891T1 (de) * 1987-03-09 1993-09-15 Merck & Co Inc Reinigung von rekombiniertem hepatitis-boberfl|chen-antigen.
NZ229260A (en) * 1988-06-03 1994-02-25 Merck & Co Inc Hepatitis b virus, expression cassette for pre-s domain, host cells and
US4962656A (en) * 1989-06-30 1990-10-16 The United States Of America As Represented By The United States Department Of Energy Control and monitoring method and system for electromagnetic forming process
LT3988B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Recombinant plasmides pfs19, pfps2-48 and pjlfds1 codingsynthesis of human hepatite b of surfice virus antigenes, methods fof producing thereof
TW340132B (en) * 1994-10-20 1998-09-11 Ibm Structure for use as an electrical interconnection means and process for preparing the same
JP4028850B2 (ja) * 2004-02-04 2007-12-26 株式会社名機製作所 ディスク基板の成形用金型

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44186B (en) * 1978-12-22 1990-04-30 Biogen Nv Process for obtaining recombinant dnk molecules
NZ199722A (en) * 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
GR76274B (cg-RX-API-DMAC7.html) * 1981-08-04 1984-08-04 Univ California
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
GB2125047B (en) * 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides

Also Published As

Publication number Publication date
AU584580B2 (en) 1989-06-01
JP2522825B2 (ja) 1996-08-07
ES532732A0 (es) 1985-10-16
ZA836658B (en) 1984-06-27
GR78982B (cg-RX-API-DMAC7.html) 1984-10-02
FI833205L (fi) 1984-03-09
JPH08317796A (ja) 1996-12-03
NO833198L (no) 1984-03-09
EP0106828A3 (en) 1985-11-21
JPH02116A (ja) 1990-01-05
JPH02231084A (ja) 1990-09-13
CA1222707A (en) 1987-06-09
IE832099L (en) 1984-03-08
EP0106828A2 (fr) 1984-04-25
DE3382704T2 (de) 1994-02-10
DK406483D0 (da) 1983-09-07
ES8600938A1 (es) 1985-10-16
CY1932A (en) 1983-09-06
PT77265A (en) 1983-09-01
PT77265B (en) 1986-02-04
MY102920A (en) 1993-03-31
AU9001491A (en) 1992-02-27
ES8602120A1 (es) 1985-11-01
JPS5971694A (ja) 1984-04-23
ES8600939A1 (es) 1985-10-16
IE60387B1 (en) 1994-07-13
ES525439A0 (es) 1985-07-01
ES532730A0 (es) 1985-10-16
DK406483A (da) 1984-03-09
NZ204952A (en) 1986-05-09
ES8506350A1 (es) 1985-07-01
JP2702899B2 (ja) 1998-01-26
IL69202A (en) 1991-08-16
DE3382704D1 (de) 1993-08-26
JPH02464A (ja) 1990-01-05
FI833205A7 (fi) 1984-03-09
AU1569288A (en) 1988-07-28
AU3131889A (en) 1989-07-20
HU196625B (en) 1988-12-28
ES532731A0 (es) 1985-11-01
ATE91718T1 (de) 1993-08-15
FI833205A0 (fi) 1983-09-07
EP0106828B1 (fr) 1993-07-21
MA19895A1 (fr) 1984-04-01
AU1675083A (en) 1984-03-15
HK1004570A1 (en) 1998-11-27

Similar Documents

Publication Publication Date Title
Senecoff et al. The FLP recombinase of the yeast 2-micron plasmid: characterization of its recombination site.
Cregg et al. High–level expression and efficient assembly of hepatitis B surface antigen in the methylotrophic yeast, Pichia pastoris
EP0073657B1 (en) Preparation of hepatitis b surface antigen in yeast
Junker et al. Expression and replication of the hepatitis B virus genome under foreign promoter control
Russell Evolutionary divergence of the mRNA transcription initiation mechanism in yeast
FI107938B (fi) Menetelmä hemoglobiinin kaltaisen yhdistelmäproteiinin valmistamiseksi
Janowicz et al. Simultaneous expression of the S and L surface antigens of hepatitis B, and formation of mixed particles in the methylotrophic yeast, Hansenula polymorpha
KR940005588B1 (ko) 효모에서 b형 간염 바이러스 단백질을 제조하는 방법
Seeger et al. Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus
NL192880C (nl) Nucleïnezuur dat voor het oppervlakte-antigeen van een Hepatitis B virus codeert, peptide waarvoor het codeert, vector die het nucleïnezuur bevat , hybride-eiwit waarvoor het in de vector ingevoegde nucleïnezuur codeert, en vaccin dat het hybride-eiwit bevat.
KR100227167B1 (ko) 인체혈청알부민의 n-말단 단편을 함유하는 융합단백질
JP2511962B2 (ja) 組換えｄｎａ分子の製造方法
US5314808A (en) Method for the transformation of cells, particularly eukaryotes by a DNA originating from viruses of hepatitis, more particularly from virus of a B viral hepatitis, and preparations containing the expression products of said DNAs
US5100784A (en) Process for the preparation of mature human serum albumin
Nassal Total chemical synthesis of a gene for hepatitis B virus core protein and its functional characterization
IE53873B1 (en) Preparation of polypeptides in vertebrate cell culture
JPS6155950B2 (cg-RX-API-DMAC7.html)
HU207532B (en) Process for marking hepatitis b s and pres2 proteines in pichia yeasts, the vectors for them and process for producing pichia stocks transformed with them
EP0105149A2 (en) Recombinant plasmid containing hepatitis B virus gene, yeast transformed with said recombinant plasmid, and production of hepatitis B virus surface antigen
KR970702365A (ko) 효모에 응집성을 부여하는 유전자 및 그 유전자 산물
US4803164A (en) Preparation of hepatitis b surface antigen in yeast
EP0182442B1 (en) Recombinant dna molecules and their method of production
JPH02116A (ja) 肝炎ｂ型ウイルスワクチン
EP0133063B1 (en) Immunologically reactive non-glycosylated amino acid chains of glycoprotein b of herpes virus types 1 and 2
Lee et al. Effect of the N‐terminal hydrophobic sequence of hepatitis B virus surface antigen on the folding and assembly of hybrid β‐galactosidase in Escherichia coli

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19830906

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19880906

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19830906

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19900723

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19910619

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19900723

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I